Company Number: 14502473

Analysis Date: 2025-07-29 12:51 UTC

1. Risk Rating: HIGH

Justification: The company is newly incorporated (since November 2022), classified as dormant with minimal financial activity, and shows negligible net assets (£1). There is no evidence of trading performance or operational cash flow. The control is concentrated in a single individual with recent director changes, which raises governance and continuity concerns.

2. Key Concerns:

• Dormant status with no trading history or revenue data, indicating uncertain operational viability.
• Extremely low net assets and shareholders’ funds (£1), which imply no capital buffer or financial strength.
• Recent changes in key appointments (director and secretary) within less than a year, suggesting possible instability or restructuring.

3. Positive Indicators:

• The company is current on all statutory filings with no overdue accounts or confirmation statements, demonstrating compliance with Companies House requirements.
• Clear ownership and control structure with a single person of significant control (PSC), which can simplify decision-making.
• Engagement of a corporate secretary (although resigned recently) indicates some initial attention to governance.

4. Due Diligence Notes:

• Investigate the company’s business plan and intended operational model given dormant status and multiple SIC codes spanning education, employment placement, retail, and pharmaceuticals.
• Clarify reasons behind director and secretary resignations and assess management stability.
• Verify any off-balance sheet arrangements or related party transactions not reflected in dormant accounts.
• Confirm plans for capitalization or commencement of trading to evaluate future solvency.